Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

Rivoltini L, Canese P, Huber V, Iero M, Pilla L, Valenti R, Fais S, Lozupone F, Casati C, Castelli C, Parmiani G.

Expert Opin Biol Ther. 2005 Apr;5(4):463-76. Review.

PMID:
15934826
2.

Immune selection in neoplasia: towards a microevolutionary model of cancer development.

Pettit SJ, Seymour K, O'Flaherty E, Kirby JA.

Br J Cancer. 2000 Jun;82(12):1900-6. Review.

3.

[Immune response and cancer].

El Hage F, Abouzahr-Rifai S, Meslin F, Mami-Chouaib F, Chouaib S.

Bull Cancer. 2008 Jan;95(1):57-67. doi: 10.1684/bdc.2008.0558. Review. French.

PMID:
18230571
4.

The immune system--is it relevant to cancer development, progression and treatment?

Prestwich RJ, Errington F, Hatfield P, Merrick AE, Ilett EJ, Selby PJ, Melcher AA.

Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12. Epub 2007 Nov 26. Review.

PMID:
18037277
5.

Strategies of tumor immune evasion.

Seliger B.

BioDrugs. 2005;19(6):347-54. Review.

PMID:
16392887
6.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Peggs KS, Quezada SA, Allison JP.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Review.

PMID:
18759925
7.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
8.

Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?

Malmberg KJ.

Cancer Immunol Immunother. 2004 Oct;53(10):879-92. Epub 2004 Jul 28. Review.

PMID:
15338206
9.

Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.

Bhutia SK, Mallick SK, Maiti TK.

Cell Biol Int. 2010 Apr 8;34(5):553-63. doi: 10.1042/CBI20090206. Review.

PMID:
20384587
10.

Cancer immunotherapy.

Baxevanis CN, Perez SA, Papamichail M.

Crit Rev Clin Lab Sci. 2009;46(4):167-89. doi: 10.1080/10408360902937809. Review.

PMID:
19650714
11.

Immune based therapies in cancer.

Krüger C, Greten TF, Korangy F.

Histol Histopathol. 2007 Jun;22(6):687-96. Review.

PMID:
17357098
12.

Tumour immunotherapy: the adjuvant treatment of the 21st century?

Bremers AJ, Kuppen PJ, Parmiani G.

Eur J Surg Oncol. 2000 Jun;26(4):418-24. Review.

PMID:
10873365
13.

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

Ahmad M, Rees RC, Ali SA.

Cancer Immunol Immunother. 2004 Oct;53(10):844-54. Epub 2004 Jun 10. Review.

PMID:
15197495
14.

Antitumour immune responses.

Mitra R, Singh S, Khar A.

Expert Rev Mol Med. 2003 Jan 13;5(3):1-19. Review.

PMID:
14987405
15.

Harnessing the immune response to treat cancer.

Steer HJ, Lake RA, Nowak AK, Robinson BW.

Oncogene. 2010 Dec 2;29(48):6301-13. doi: 10.1038/onc.2010.437. Epub 2010 Sep 20. Review.

PMID:
20856204
16.

Targeted therapies to improve tumor immunotherapy.

Begley J, Ribas A.

Clin Cancer Res. 2008 Jul 15;14(14):4385-91. doi: 10.1158/1078-0432.CCR-07-4804. Review.

17.

Cancer immunotherapy: the past, the present and the future.

Parish CR.

Immunol Cell Biol. 2003 Apr;81(2):106-13. Review.

18.

Immune escape of tumors: apoptosis resistance and tumor counterattack.

Igney FH, Krammer PH.

J Leukoc Biol. 2002 Jun;71(6):907-20. Review.

19.

Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.

Croci DO, Zacarías Fluck MF, Rico MJ, Matar P, Rabinovich GA, Scharovsky OG.

Cancer Immunol Immunother. 2007 Nov;56(11):1687-700. Epub 2007 Jun 15. Review.

PMID:
17571260
20.

Targeting costimulatory pathways for tumor immunotherapy.

Ward RC, Kaufman HL.

Int Rev Immunol. 2007 May-Aug;26(3-4):161-96. Review.

PMID:
17558743
Items per page

Supplemental Content

Write to the Help Desk